Trombovar I.V.

Trombovar I.V. contains sodium tetradecyl sulfate, a sclerosing agent used for intravenous treatment of varicose veins and spider veins. This injectable solution helps reduce the appearance of vascular conditions by collapsing targeted veins. Suitable for professional administration in clinical settings.

Trombovar I.V. is primarily used to treat varicose veins and spider veins by causing the targeted vein to collapse and fade over time. It is administered intravenously by healthcare professionals to manage visible vascular conditions. The solution works by irritating the vein lining, leading to closure of the affected vein.

After administration, patients may notice a gradual reduction in the appearance of treated veins as blood flow is redirected to healthier vessels. Mild discomfort, swelling, or bruising at the injection site is common. The treated area may appear lighter or less visible over several weeks.

This medication should only be handled and administered by trained healthcare professionals in a clinical setting. Proper sterile technique is essential to minimize infection risk. Patients should avoid strenuous activity or prolonged standing immediately after treatment to support healing.

No significant drug interactions have been widely reported for sodium tetradecyl sulfate. However, patients using blood thinners or other vascular treatments should inform their healthcare provider. Alcohol and certain supplements may increase bruising risk but do not directly interact with the medication.